Chemical constituents and ACE inhibitory activity of desert plant Suaeda physophora Pall.  by Men, Ruizhi et al.
Chinese Pharmaceutical AssociationInstitute of Materia Medica, Chinese Academy of Medical Sciences
Acta Pharmaceutica Sinica B
Acta Pharmaceutica Sinica B 2013;3(5):328–3322211-3835 & 2013 Ins
Elsevier B.V. All righ
http://dx.doi.org/10.10
nCorresponding aut
E-mail address: li
Peer review under rwww.elsevier.com/locate/apsb
www.sciencedirect.comORIGINAL ARTICLE
Chemical constituents and ACE inhibitory activity of
desert plant Suaeda physophora Pall.Ruizhi Mena, Ning Lia,n, Yachao Xinga, Yingzhan Tanga, Chengyu Tanb,
Fantong Mengb, Juan Zhangc, Hui Nic, Xiaoguang JiacaKey Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Traditional Chinese Medicine,
Shenyang Pharmaceutical University, Shenyang 110016, China
bMarine Environmental Engineering College, Dalian Ocean University, Dalian 116023, China
cXinjiang Institute of Chinese Materia Medica and Ethnodrug, Urumqi 830002, China
Received 20 May 2013; revised 29 June 2013; accepted 15 July 2013KEY WORDS
Desert plant;
Suaeda physophora Pall.;
Chemical constituents;
ACE inhibitory activitytitute of Materia Me
ts reserved.
16/j.apsb.2013.07.00
hor. Tel.: +86 24 23
ningsypharm@163.c
esponsibility of InstAbstract Suaeda physophora Pall. is a kind of desert plant mostly growing in saline habitats in Xinjiang
Uygur Autonomous Region. In order to have a better utilization of halophytes, a screening for ACE
inhibitors from halophytes growing in Xinjiang was carried out. The result showed that the 70% EtOH
extract and n-BuOH extract of S. physophora Pall. possessed signiﬁcant ACE inhibitory activities. So we
focused on its biochemical constituents ﬁrstly. One new quinazoline alkaloid, namely Suaedine (1), along
with six known compounds (2–7) was isolated from the aerial parts of S. physophora Pall. The structure of
the new quinazoline alkaloid was established by one- and two-dimensional nuclear magnetic resonance,
optical rotation and mass spectrometry analysis. The ﬂavonoid compounds (2–4) and phenolic compound
(5) exhibited signiﬁcant ACE activities. It was the ﬁrst time to focus on the chemical constituents and
bioactivities of this plant.
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Chemical constituents and ACE inhibitory activity of desert plant Suaeda physophora Pall. 3291. Introduction
Suaeda physophora Pall. was a kind of desert plant of Suaeda
genus growing in saline habitats at about 500–700 m above sea
level in Xinjiang Uygur Autonomous Region and west of Gansu
province in China. It is one of the main host plants of traditional
Chinese medicine Cistanche tubulosa (Schenk) R. Wight. And also
the plant was used as animal feeding stuffs and for prevention
from desertiﬁcation with a rich resource1. Some studies have
revealed that the extract of some species of Suaeda genus could be
used for prevention and treatment of heart disease and hyperten-
sion2. However, previous research of this plant mainly focused on
plant physiology and salt tolerance3–5.
Angiotensin I-converting enzyme (ACE) played a critical
physiological role in the regulation of blood pressure6. It could
increase blood pressure by converting an inactive form of
decapeptide (angiotensin I) into a potent vasoconstrictor
angiotensin-II (anoctapeptide) and inactivating catalytic function
of bradykinin, which had depressor action7. According to tradi-
tional use of Suaeda genus plants, we carried out a screening for
ACE inhibitors from halophytes growing in Xinjiang for better
utilization of halophytes. The primary result showed that the 70%
EtOH extract and n-BuOH extract of S. physophora Pall.
possessed signiﬁcant ACE inhibitory activities.
Seven compounds were isolated from the n-BuOH extract and
EtOAc extract and identiﬁed to be (10bS,2′S)-1, 5, 6, 10b-
tetrahydro-8,9-[2′-(2ʺ-hydroxy-2ʺ-carboxylalkenyl)-[1′,3′]dioxolo]-2H-
pyrrolo[2,1-a]isoquinoline-3-one (1), isorhamnetin-3-O-β-D-rutino-
side (2), rutin (3), quercetin (4), 2-hydroxybenzoic acid (5), β-
sitosterol (6) and daucosterol (7). The structure of the new
quinazoline alkaloid (1) was established by one- and two-
dimensional NMR and mass spectrometry analysis. All com-
pounds were isolated from this plant for the ﬁrst time, and
compounds 1, 2, 3, 4, 5, and 7 were isolated from Suaeda genus
ﬁrstly. The ACE inhibiting activities of the compounds were
assayed respectively. The ﬂavonoid compounds (2, 3 and 4) and
phenolic compound (5) exhibited signiﬁcant ACE activities. It was
the ﬁrst time to focus on the chemical constituents and bioactivities
of this plant.2. Results and discussion
Compound 1 was isolated as lilac powder. Its molecular formula
was assigned as C16H15NO6 by HR-ESI-MS (m/z: 317.1040, calcd.
317.0899). NMR spectrum (1H NMR: 600 MHz, 13C NMR:
150 MHz) and HSQC (Table 1) exhibited a four substituented
benzene ring [δ 125.0 (C-6a), 116.8 (C-7), 146.6 (C-8), 146.4 (C-
9), 113.0 (C-10), 129.5 (C-10a)] with two hydrogen signals on the
benzene ring at δ 7.03 (1H, s, H-7), 7.01 (1H, s, H-10), two
carbonyls [δ 173.1 (C-3), 166.1 (2ʺ-COOH)], a double bond
[δ 7.56 (H-1ʺ); 142.5 (C-1ʺ), 153.5 (C-2ʺ)], four methenes
[δ 28.3 (C-1), 32.2 (C-2), 37.8 (C-5), 28.4 (C-6)], two methines
[δ 56.8 (C-10b), 101.4 (C-2′)] and active hydrogen signals at
δ 12.41 (1H, s, 2ʺ-COOH), 13.06 (1H, s, 2ʺ-OH).
H-10b (δ 4.54) showed HMBC correlations to C-6a, C-10a and
C-10. So, C-10b was connected to the C10a on the benzene ring
core. Other HMBC correlations of H-1/C-10b, H-2/C-10b and H-
2/C-3 together indicated the link of benzene ring–(10a)–C10b–
C1–C2–C3 (Fig. 1). HMBC correlations of H-6/C-6a, H-6/C-7 and
H-6/C-10a identiﬁed that C-6 was connected to the C-6a on the
benzene ring core. And HMBC correlation H-6/C-5, H-5/C-6atogether indicated the connection of benzene ring–(6a)–C6–C5.
The HMBC correlation of H-5/C-10b, as well as the chemical shift
of C-10b (δ 56.8), H-10b (δ 4.54) supported that C-5 was
connected to C-10b through N-atom.
H-2′ (δ 5.82) showed HMBC correlations to C-8, C-9, and the
chemical shift of C-2′ (δ 101.4), H-2′ (δ 5.82) together demon-
strated that C-2′ was connected to benzene ring through oxygen
atom. From the remaining signals, an alkenyl (C-1ʺ, C-2ʺ),
a carboxyl (2ʺ-COOH) and a hydroxy (2ʺ-OH) could be clearly
observed. The HMBC correlations H-2′/C-1ʺand H-2/C-2ʺ sup-
ported the link of C2′–C1ʺ–C2ʺ. Then the carboxyl and hydroxy
were therefore connecting to C-2ʺ. So, we determined the plane
structure of compound 1. The main HMBC correlations are
provided in Fig. 2.
The conﬁguration of 1 was assigned based on NOESY
spectrum and optical rotation. H-10b/H-2′ NOESY correlation
was observed, revealing that they were on the same face of the
molecule and relatively close. The conﬁguration of C-10b was
determined by comparing the chemical shift of H-10b [δ 4.54 (1H,
t, J¼8.3 Hz)] in 1 with that in the analogs, named (10bS)8,9-
dihydroxy-1, 5, 6, 10b-tetrahydro-2H-pyrrolo[2, 1-a]isoquinoline-
3-one with H-10b [δ 4.40 (1H, t, J¼8.0 Hz)]8,9. The optical
rotation of 1 is [α]25D ¼348.8 (c¼1.4, MeOH), and that of
(10bS)8,9-dihydroxy-1,5,6,10b-tetrahydro-2H-pyrrolo[2,1-a]iso-
quinolin-3-one is [α]25D ¼197. So, the absolute conﬁgurations of
C-10b and C-2′ were all S. Compound 1 was elucidated as (10bS,
2′S)-1,5,6,10b-tetrahydro-8,9 [2′-(2ʺ-hydroxy-2ʺ-carboxylalkenyl)-
[1′,3′]dioxolo]-2H-pyrrolo[2,1-a]isoquinoline-3-one.
By comparing their physical and spectral data (1H NMR, 13C
NMR) with those reported, the known compounds were character-
ized to be isorhamnetin-3-O-β-D-rutinoside (2)10, rutin (3)11,
quercetin (4)12, 2-hydroxybenzoic acid (5)13, β-sitosterol (6)14
and daucosterol (7)14. The structures of the isolated compounds are
shown in Fig. 3.
The ACE inhibitory activities of the extracts and isolated
compounds were tested on different concentrations. The results
are listed in Figs. 4 and 5. The n-BuOH extraction was identiﬁed
as the active part because of its signiﬁcant ACE inhibitory activity
with 83.5% inhibiting rate at 100 mg/mL and 70.1% inhibiting rate
at 50 mg/mL. Furthermore the puriﬁed compounds (1–4) from the
active fraction (n-BuOH extract) were evaluated accordingly. The
ﬂavonoid compounds (2–4) were the material basis of ACE
inhibitory activity for the active part on the basis of the chemical
and biological data while the new compound (1) had no signiﬁcant
ACE inhibitory activity with 411.3% inhibiting rate at 10 mg/
mL, 511.3% inhibiting rate at 20 mg/mL and 560.3% inhibit-
ing rate at 40 mg/mL. It was suggested to be a potential ACE
agonist.3. Experimental
3.1. General experimental procedures
Optical rotations were measured on a PerkinIFS-55 polarimeter.
HR-ESI-MS spectra were obtained by a Bruker APEX 7.0 T FT-
MS apparatus in m/z. NMR spectra were recorded on Bruker
ARX-300 and ARX-600 spectrometers, using pyridine-d5 or
DMSO-d6 as solvents with TMS as the internal standard. Silica
gel (SiO2: 200–300 mesh, Qingdao Marine Chemical Company,
China), Sephadex LH-20 (Pharmacia, Co., Switzerland), Macro-
porous resin HPD-100 (Cangzhou Bonchem Co., Ltd., China) and
Table 1 NMR and HMBC data of compound 1 (in pyridine-d5).
No. 1H NMR 13C NMR HMBC
1 1.65 (1H, m) 28.3 C3, C10b
2.36 (1H, m) C10a, C2, C3
2 2.36 (1H, m) 32.2 C1, C3
2.43 (1H, m) C10b, C1
3 – 173.1 –
4 – –
5 2.91 (1H, m) 37.8 C6a
4.32 (1H, m)
6 2.49 (1H, m) 28.4 C6a, C5
2.76 (1H, m) C6a,C7
6a – 125.0 –
7 7.03 (1H, s) 116.8 C8, C9, C10a, C6
8 – 146.6 –
9 – 146.4 –
10 7.01 (1H, s) 113.0 C8, C9, C6a, C10b
10a – 129.5 –
10b 4.54 (1H, t, J¼8.3 Hz) 56.8 C10a, C10
2′ 5.82 (1H, d, J¼7.3 Hz) 101.4 C1ʺ
1ʺ 7.56 (1H, d, J¼7.2 Hz) 142.5 2ʺ-COOH, C2′, C2ʺ
2ʺ – 153.5 –
2ʺ-COOH 12.41 (1H, s) 166.1 –
2ʺ-OH 13.06 (1H, s) –
Figure 1 The structure of compound 1.
Figure 2 Key HMBC and NOESY correlations observed in
compound 1.
Figure 3 The structure of compounds isolated from Suaeda
physophora Pall.
R. Men et al.330polyamide (Taizhou City Luqiao Sijia Biochemical Plastic Fac-
tory, China) were used for column chromatography separation.
Silica gel GF254 for TLC (SiO2: 200–300 mesh) was obtained from
Qingdao Marine Chemical Company, China. Other chemical
solvents in this experiment were all analytical grades and obtained
from Shandong Yuwang Co., LTD. Chemical Engineering Branch
and Tianjin Damao Chemical Reagent Co.3.2. Plant material
The aerial parts of S. physophora Pall. were collected from
Xinjiang Uygur Autonomous Region of China, in June 2011.
The plant material was identiﬁed by Prof. Xiaoguang Jia.
(Xinjiang Institute of Chinese Materia Medica and Ethnodrug).
A voucher specimen (No. 20110613) is deposited in School of
Figure 4 The ACE inhibiting activities of different extracts of
Suaeda physophora Pall.
Figure 5 The ACE inhibiting activities of compounds 2–4. Captopril
was used as a positive control with IC50 value 6.95 mg/mL.
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University. The whole plants of S. physophora Pall. were
harvested and air-dried at room temperature in the dark.3.3. Extraction and isolation
The air-dried plant (5.0 kg) of S. physophora Pall. was ﬁnely cut
and extracted three times (3 2 h) with reﬂuxing EtOH (1 8 L).
Evaporation of the solvent under reduced pressure provided the
ethanolic extract (500 g). The extract was dissolved and suspended
in H2O (2.5 L), and partitioned with petroleum ether (3 2.5 L),
EtOAc (3 2.5 L) and n-BuOH (3 2.5 L) to yield petroleum
ether extract (16.8 g), EtOAc extract (38 g) and n-BuOH extract
(130.5 g) respectively. The n-BuOH fraction (130.5 g) was sub-
jected to column chromatography on silica gel (200–300 mesh,
130 cm 8 cm, 1000 g) gradiently eluted with CH2Cl2/MeOH
(100:0–0:1) to give 10 fractions (F1–F10). Compound 1 (6.7 mg)
was separated by re-silica gel chromatography from F3. Compound
2 (8.3 mg) was isolated from F6 by silica gel chromatography and
puriﬁed on Sephadex LH-20 (MeOH). F5 (0.8 g) was subjected to
Sephedax LH-20 (80 cm 2 cm) eluted with MeOH to give
compound 3 (20.5 mg). Compound 4 (15.0 mg) was isolated from
F2 puriﬁed by silica gel, polyamide and Sephadex LH-20
chromatography. The EtOAc fraction (38 g) was subjected to
column chromatography on silica gel (200–300 mesh, 130 cm
8 cm, 300 g) gradiently eluted with petroleum ether/EtOAc
(100:0–0:1) to give six fractions (Fr.1–Fr.6). Compound 5
(5.2 mg) was puriﬁed from Fr.5 using macroporous resin chroma-
tography and the recrystallization method. Compounds 6(15.0 mg) and 7 (25.2 mg) were separated from Fr.4 and Fr.1,
respectively.3.4. Identiﬁcation
Suaedine (compound 1): lilac powder; [α]25D ¼348.8 (c¼1.4,
MeOH). HR-ESI-MS m/z: 317.1040, (calcd. for C16H15NO6,
317.0899). 1H and 13C NMR data, see in Table 1.3.5. Angiotensin I-converting enzyme assay15
1 U ACE was dissolved in 5 mL borate buffer (pH 8.3), and then
added to the enzyme solution (2:1). Hip–His–Leu (7.6 mM) was
prepared in borate buffer (0.2 M, pH 8.3, containing 608 mM of
NaCl). Brieﬂy, 15 μL ACE extract was incubated with 5 μL
samples for 30 min at 37 1C in 0.5 mL centrifuge tube. Then,
25 μL HHL was added and incubated for 15 min at 37 1C.
Afterward, the action was terminated by adding 5 μL 10% TFA.
The reaction buffer was directly analyzed in an HPLC autoinjec-
tion system (mobile phase: 30% methanol–1 mL TFA–0.5 mL
glacial acetic acid (pH 3–3.3), 70% methanol–1 mL TFA–0.5 mL
glacial acetic acid (pH 3–3.3) eluted in gradient, AR; detection
wavelength: 228 nm; ﬂow rate: 1 mL/min). The resulting hippuric
acid was quantitatively analyzed by HPLC. Captopril was used as
positive control with IC50 value 6.95 mg/mL.Acknowledgment
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